These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 20047711)

  • 1. Preclinical characterization of BRL 44408: antidepressant- and analgesic-like activity through selective alpha2A-adrenoceptor antagonism.
    Dwyer JM; Platt BJ; Rizzo SJ; Pulicicchio CM; Wantuch C; Zhang MY; Cummons T; Leventhal L; Bender CN; Zhang J; Kowal D; Lu S; Rajarao SJ; Smith DL; Shilling AD; Wang J; Butera J; Resnick L; Rosenzweig-Lipson S; Schechter LE; Beyer CE
    Int J Neuropsychopharmacol; 2010 Oct; 13(9):1193-205. PubMed ID: 20047711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On the mechanism of antidepressant-like action of berberine chloride.
    Kulkarni SK; Dhir A
    Eur J Pharmacol; 2008 Jul; 589(1-3):163-72. PubMed ID: 18585703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Centhaquin antinociception in mice is mediated by α2A- and α2B- but not α2C-adrenoceptors.
    Bhalla S; Ali I; Andurkar SV; Gulati A
    Eur J Pharmacol; 2013 Sep; 715(1-3):328-36. PubMed ID: 23712005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological characterisation of a structurally novel α2C-adrenoceptor antagonist ORM-10921 and its effects in neuropsychiatric models.
    Sallinen J; Holappa J; Koivisto A; Kuokkanen K; Chapman H; Lehtimäki J; Piepponen P; Mijatovic J; Tanila H; Virtanen R; Sirviö J; Haapalinna A
    Basic Clin Pharmacol Toxicol; 2013 Oct; 113(4):239-49. PubMed ID: 23718812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. S 15535, a novel benzodioxopiperazine ligand of serotonin (5-HT)1A receptors: I. Interaction with cloned human (h)5-HT1A, dopamine hD2/hD3 and h alpha2A-adrenergic receptors in relation to modulation of cortical monoamine release and activity in models of potential antidepressant activity.
    Millan MJ; Newman-Tancredi A; Rivet JM; Brocco M; Lacroix P; Audinot V; Cistarelli L; Gobert A
    J Pharmacol Exp Ther; 1997 Jul; 282(1):132-47. PubMed ID: 9223549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analgesia, enhancement of spinal morphine antinociception, and inhibition of tolerance by ultra-low dose of the α2A-adrenoceptor selective antagonist BRL44408.
    Milne B; Jhamandas K; Sutak M; Grenier P; Cahill CM
    Eur J Pharmacol; 2014 Nov; 743():89-97. PubMed ID: 25242119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Further analysis of the inhibition by agmatine on the cardiac sympathetic outflow: Role of the α
    Cobos-Puc L; Aguayo-Morales H; Ventura-Sobrevilla J; Luque-Contreras D; Chin-Chan M
    Eur J Pharmacol; 2017 Jun; 805():75-83. PubMed ID: 28315344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clonidine and guanfacine attenuate phencyclidine-induced dopamine overflow in rat prefrontal cortex: mediating influence of the alpha-2A adrenoceptor subtype.
    Jentsch JD; Sanchez D; Elsworth JD; Roth RH
    Brain Res; 2008 Dec; 1246():41-6. PubMed ID: 18977208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, Sustainable Synthesis and Biological Evaluation of a Novel Dual α2A/5-HT7 Receptor Antagonist with Antidepressant-Like Properties.
    Canale V; Kotańska M; Dziubina A; Stefaniak M; Siwek A; Starowicz G; Marciniec K; Kasza P; Satała G; Duszyńska B; Bantreil X; Lamaty F; Bednarski M; Sapa J; Zajdel P
    Molecules; 2021 Jun; 26(13):. PubMed ID: 34201675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological characterization and CNS effects of a novel highly selective alpha2C-adrenoceptor antagonist JP-1302.
    Sallinen J; Höglund I; Engström M; Lehtimäki J; Virtanen R; Sirviö J; Wurster S; Savola JM; Haapalinna A
    Br J Pharmacol; 2007 Feb; 150(4):391-402. PubMed ID: 17220913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. S32212, a novel serotonin type 2C receptor inverse agonist/α2-adrenoceptor antagonist and potential antidepressant: II. A behavioral, neurochemical, and electrophysiological characterization.
    Dekeyne A; Brocco M; Loiseau F; Gobert A; Rivet JM; Di Cara B; Cremers TI; Flik G; Fone KC; Watson DJ; Papp M; Sharp T; Serres F; Cespuglio R; Olivier B; Chan JS; Lavielle G; Millan MJ
    J Pharmacol Exp Ther; 2012 Mar; 340(3):765-80. PubMed ID: 22178753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of acute and chronic reboxetine treatment on stress-induced monoamine efflux in the rat frontal cortex.
    Page ME; Lucki I
    Neuropsychopharmacology; 2002 Aug; 27(2):237-47. PubMed ID: 12093597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacology of basimglurant (RO4917523, RG7090), a unique metabotropic glutamate receptor 5 negative allosteric modulator in clinical development for depression.
    Lindemann L; Porter RH; Scharf SH; Kuennecke B; Bruns A; von Kienlin M; Harrison AC; Paehler A; Funk C; Gloge A; Schneider M; Parrott NJ; Polonchuk L; Niederhauser U; Morairty SR; Kilduff TS; Vieira E; Kolczewski S; Wichmann J; Hartung T; Honer M; Borroni E; Moreau JL; Prinssen E; Spooren W; Wettstein JG; Jaeschke G
    J Pharmacol Exp Ther; 2015 Apr; 353(1):213-33. PubMed ID: 25665805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preclinical pharmacology of TP1, a novel potent triple reuptake inhibitor with antidepressant properties.
    Tian JW; Jiang WL; Zhong Y; Meng Q; Gai Y; Zhu HB; Hou J; Xing Y; Li YX
    Neuroscience; 2011 Nov; 196():124-30. PubMed ID: 21925241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. S32212, a novel serotonin type 2C receptor inverse agonist/α2-adrenoceptor antagonist and potential antidepressant: I. A mechanistic characterization.
    Millan MJ; Mannoury la Cour C; Chanrion B; Dupuis DS; Di Cara B; Audinot V; Cussac D; Newman-Tancredi A; Kamal M; Boutin JA; Jockers R; Marin P; Bockaert J; Muller O; Dekeyne A; Lavielle G
    J Pharmacol Exp Ther; 2012 Mar; 340(3):750-64. PubMed ID: 22178752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of antidepressant activity of 1-(7-methoxy-2-methyl-1,2,3,4-tetrahydro-isoquinolin-4-YL)-cyclohexanol, a β-substituted phenylethylamine in mice.
    Dhir A; Malik S; Kessar SV; Singh KN; Kulkarni SK
    Eur Neuropsychopharmacol; 2011 Sep; 21(9):705-14. PubMed ID: 21277753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. α
    Cong Z; Li D; Tao Y; Lv X; Zhu X
    J Cell Physiol; 2020 Oct; 235(10):6905-6914. PubMed ID: 32003020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antidepressant-like properties of three new α2-adrenoceptor antagonists.
    Muguruza C; Rodríguez F; Rozas I; Meana JJ; Urigüen L; Callado LF
    Neuropharmacology; 2013 Feb; 65():13-9. PubMed ID: 22982479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sustained impairment of α2A-adrenergic autoreceptor signaling mediates neurochemical and behavioral sensitization to amphetamine.
    Doucet EL; Bobadilla AC; Houades V; Lanteri C; Godeheu G; Lanfumey L; Sara SJ; Tassin JP
    Biol Psychiatry; 2013 Jul; 74(2):90-8. PubMed ID: 23332355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of α2A-Adrenoceptors Ameliorates Dextran Sulfate Sodium-Induced Acute Intestinal Inflammation in Mice.
    Zádori ZS; Tóth VE; Fehér Á; Al-Khrasani M; Puskár Z; Kozsurek M; Timár J; Tábi T; Helyes Z; Hein L; Holzer P; Gyires K
    J Pharmacol Exp Ther; 2016 Sep; 358(3):483-91. PubMed ID: 27418171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.